Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | PTPN7 | P35236 | 5/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2122845 | 0.79 | ALDH1A1 (0.37) | FFAR1TDP1ALDH1A1SMN1; SMN2CA2 | |
| SCHEMBL2122055 | 0.79 | HMGCR (0.44) | HMGCRPTPN7TDP1ALDH1A1RECQL | |
| SCHEMBL12003514 | 0.77 | HMGCR (0.47) | HMGCRPTPN7TDP1ALDH1A1RECQL | |
| SCHEMBL997133 | 0.77 | HMGCR (0.47) | HMGCRPTPN7TDP1ALDH1A1RECQL | |
| SCHEMBL995365 | 0.75 | HMGCR (0.41) | HMGCRPTPN7TDP1ALDH1A1RECQL | |
| SCHEMBL2123154 | 0.75 | TDP1 (0.50) | FFAR1TDP1ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL9322780 | 0.73 | HMGCR (0.40) | HMGCRPTPN7TDP1ALDH1A1RECQL | |
| SCHEMBL998012 | 0.73 | HMGCR (0.40) | HMGCRPTPN7TDP1ALDH1A1RECQL | |
| SCHEMBL16594184 | 0.73 | HMGCR (0.47) | HMGCRPTPN7TDP1ALDH1A1RECQL | |
| SCHEMBL995772 | 0.72 | PTPN7 (0.50) | HMGCRPTPN7TDP1ALDH1A1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2442783-B1 | NOVEL DEODORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | ROBERTET SA (FR) | 2017-08-09 | — | — | EP | claimed |
| US-9265852-B2 | Deordorising compositions and deodorising products containing same | ROBERTET S.A. (FR) | 2016-02-23 | — | — | US | claimed |
| US-20120201778-A1 | NOVEL DEORDORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | ROBERTET S.A. (FR) | 2012-08-09 | — | — | US | claimed |
| WO-2010146258-A2 | NOVEL DEODORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | ROBERTET S.A. (FR) | 2010-12-23 | — | — | WO | claimed |
| CN-115322211-B | Preparation method of alkenyl substituted-alpha-hydroxy borate compound | 香港科技大学深圳研究院 | 2025-02-25 | — | — | CN | disclosed |
| EP-2442783-B1 | NOVEL DEODORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | ROBERTET SA (FR) | 2017-08-09 | — | — | EP | disclosed |
| US-9265852-B2 | Deordorising compositions and deodorising products containing same | ROBERTET S.A. (FR) | 2016-02-23 | — | — | US | disclosed |
| US-20120201778-A1 | NOVEL DEORDORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | ROBERTET S.A. (FR) | 2012-08-09 | — | — | US | disclosed |
| EP-2442783-A2 | NOVEL DEODORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | Robertet S.A. (FR) | 2012-04-25 | — | — | EP | disclosed |
| EP-1753746-B8 | NOVEL PYRROLE DERIVATIVES WITH ANGIOTENSIN II ANTAGONIST ACTIVITY | ROTTAPHARM SPA (IT) | 2012-02-15 | — | — | EP | disclosed |
| EP-1753746-B1 | NOVEL PYRROLE DERIVATIVES WITH ANGIOTENSIN II ANTAGONIST ACTIVITY | ROTTAPHARM SPA (IT) | 2011-07-27 | — | — | EP | disclosed |
| US-7906501-B2 | Pyrrole derivatives with angiotensin II antagonist activity | ROTTAPHARM S.P.A. (IT) | 2011-03-15 | — | — | US | disclosed |
| WO-2010146258-A2 | NOVEL DEODORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | ROBERTET S.A. (FR) | 2010-12-23 | — | — | WO | disclosed |
| US-20070244170-A1 | Novel Pyrrole Derivatives with Angiotensin II Antagonist Activity | ROTTAPHARM BIOTECH S.R.L. (IT) | 2007-10-18 | — | — | US | disclosed |
| EP-1753746-A2 | NOVEL PYRROLE DERIVATIVES WITH ANGIOTENSIN II ANTAGONIST ACTIVITY | ROTTAPHARM S.P.A. (IT) | 2007-02-21 | — | — | EP | disclosed |
| WO-2005105789-A2 | NOVEL PYRROLE DERIVATIVES WITH ANGIOTENSIN II ANTAGONIST ACTIVITY | ROTTAPHARM S.P.A. (IT) | 2005-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244170-A1 | Novel Pyrrole Derivatives with Angiotensin II Antagonist Activity | AGTR2, AGTR1, REN | HMGCR 3305/4885FFAR1 757/4885PTPN7 1363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.